Anidulafungin how supplied

Revision as of 01:10, 9 January 2014 by Ahmed Zaghw (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Anidulafungin
Eraxis® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

How Supplied/Storage And Handling

How Supplied

ERAXIS (anidulafungin) for Injection is supplied in a single-use vial of sterile, lyophilized, preservative-free, powder. ERAXIS (anidulafungin) is available in the following packaging configuration:[1]

Single-Use Vial of ERAXIS 50 mg

One - 50 mg vial, NDC 0049-0114-28

Single-Use Vial of ERAXIS 100 mg

One - 100 mg vial, NDC 0049-0116-28

References

  1. "ERAXIS (ANIDULAFUNGIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG]".

Adapted from the FDA Package Insert.